Arcellx (ACLX) Total Liabilities (2021 - 2025)
Arcellx (ACLX) recorded quarterly Total Liabilities of $201.6 million in Q4 2025, down 6.28% quarter-over-quarter from $215.1 million in Q3 2025, and down 21.4% on a YoY basis from $256.5 million in Q4 2024.
Arcellx (ACLX) Total Liabilities (2021 - 2025) Analysis & Trends
Arcellx's Total Liabilities history runs 5 years deep, the most recent figure standing at $201.6 million for Q4 2025.
- In Q4 2025, Total Liabilities fell 21.4% year-over-year to $201.6 million; the TTM figure through Dec 2025 stood at $201.6 million (down 21.4% YoY), while the FY2025 annual figure was $201.6 million, down 21.4% from the prior year.
- Total Liabilities was $201.6 million for Q4 2025 at Arcellx, down from $215.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $348.1 million in Q3 2023 to a low of $16.9 million in Q4 2021.
- Historically, Total Liabilities has averaged $192.2 million across 5 years, with a median of $221.0 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities plunged 74.34% in 2022, then jumped 1575.82% in 2023.
- A 5-year view of Total Liabilities shows it stood at $16.9 million in 2021, then jumped by 543.47% to $108.9 million in 2022, then jumped by 212.09% to $339.8 million in 2023, then decreased by 24.49% to $256.5 million in 2024, then decreased by 21.4% to $201.6 million in 2025.
- The last three Total Liabilities figures came in at $201.6 million (Q4 2025), $215.1 million (Q3 2025), and $226.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 201.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 201.64 Mn |
| Sep 30, 2025 | 215.14 Mn |
| Jun 30, 2025 | 226.86 Mn |
| Mar 31, 2025 | 231.18 Mn |
| Dec 31, 2024 | 256.54 Mn |
| Sep 30, 2024 | 281.89 Mn |
| Jun 30, 2024 | 247.14 Mn |
| Mar 31, 2024 | 283.12 Mn |
| Dec 31, 2023 | 339.75 Mn |
| Sep 30, 2023 | 348.09 Mn |
| Jun 30, 2023 | 329.86 Mn |
| Mar 31, 2023 | 319.23 Mn |
| Dec 31, 2022 | 108.86 Mn |
| Sep 30, 2022 | 101.04 Mn |
| Jun 30, 2022 | 51.04 Mn |
| Mar 31, 2022 | 19.05 Mn |
| Dec 31, 2021 | 16.92 Mn |
| Sep 30, 2021 | 103.80 Mn |
| Jun 30, 2021 | 88.75 Mn |
| Mar 31, 2021 | 74.23 Mn |